The protein levels of SH3GL1 (SH3 Domain Containing GRB2 Like 1, Endophilin A2) were linked to tumor progression, metastasis, and worse patient outcomes in many cancer types (Baldassarre et al., 2015; Baldassarre et al., 2017). This evidence concerns the gene SH3GL1 and neoplasm.